(Corrects keyword used by media clients to “ABBVIE-MIGRAINE/STUDY” from “ABBVIE-MIGRANE STUDY/”)
Sept 10 (Reuters) – AbbVie said on Thursday its migraine treatment had met the main goal of a late-stage study testing it as a preventive treatment of menstrual migraine in adults.
(Reporting by Sneha S K in Bengaluru; Editing by Shreya Biswas)
Comments